Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
description
Transcript of Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
![Page 1: Hippisley-Cox J, Coupland C. Heart 2010;96:939-47](https://reader035.fdocuments.us/reader035/viewer/2022062816/56813b68550346895da46ba5/html5/thumbnails/1.jpg)
Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
![Page 2: Hippisley-Cox J, Coupland C. Heart 2010;96:939-47](https://reader035.fdocuments.us/reader035/viewer/2022062816/56813b68550346895da46ba5/html5/thumbnails/2.jpg)
Baseline characteristics of new users of statins and non-users of statins aged 30-84 years in the QResearch derivation and THIN validation cohorts
Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
![Page 3: Hippisley-Cox J, Coupland C. Heart 2010;96:939-47](https://reader035.fdocuments.us/reader035/viewer/2022062816/56813b68550346895da46ba5/html5/thumbnails/3.jpg)
Adjusted HRs (95% CI) for moderate to severe myopathyModels also adjusted for age and body mass index
Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
![Page 4: Hippisley-Cox J, Coupland C. Heart 2010;96:939-47](https://reader035.fdocuments.us/reader035/viewer/2022062816/56813b68550346895da46ba5/html5/thumbnails/4.jpg)
Validation statistics for each model in the THIN and QResearch validation cohorts
Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
![Page 5: Hippisley-Cox J, Coupland C. Heart 2010;96:939-47](https://reader035.fdocuments.us/reader035/viewer/2022062816/56813b68550346895da46ba5/html5/thumbnails/5.jpg)
Adjusted HRs (95% CI) for acute renal failure Models also adjusted for age and body mass index
Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
![Page 6: Hippisley-Cox J, Coupland C. Heart 2010;96:939-47](https://reader035.fdocuments.us/reader035/viewer/2022062816/56813b68550346895da46ba5/html5/thumbnails/6.jpg)
Adjusted HR (95% CI) for moderate/serious
liver dysfunction
Models also adjusted for age and body mass index
Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
![Page 7: Hippisley-Cox J, Coupland C. Heart 2010;96:939-47](https://reader035.fdocuments.us/reader035/viewer/2022062816/56813b68550346895da46ba5/html5/thumbnails/7.jpg)
Adjusted HR (95% CI) for cataract
Models also adjusted forage and body mass index
Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
![Page 8: Hippisley-Cox J, Coupland C. Heart 2010;96:939-47](https://reader035.fdocuments.us/reader035/viewer/2022062816/56813b68550346895da46ba5/html5/thumbnails/8.jpg)
Predicted to observed risk of each outcome using the QResearch database
Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
![Page 9: Hippisley-Cox J, Coupland C. Heart 2010;96:939-47](https://reader035.fdocuments.us/reader035/viewer/2022062816/56813b68550346895da46ba5/html5/thumbnails/9.jpg)
Numbers needed to harm (NNH) or numbers needed to treat (NNT) and numbers of extra or prevented cases, for each outcome over 5 years in patients aged 35-74 free of
cardiovascular disease at baseline with QRISK2 score of 20%+
Hippisley-Cox J, Coupland C. Heart 2010;96:939-47